Molecular Technologies Laboratories LLC

États‑Unis d’Amérique

 
Quantité totale PI 12
Rang # Quantité totale PI 128 883
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 82 074
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

5 1
3 0
3 0
0
 
Dernier brevet 2025 - Growth hormone receptor antagoni...
Premier brevet 2018 - Pegylated growth hormone antagon...
Dernière marque 2022 - RAPID INNOVATE MODEL
Première marque 2022 - RAPID INNOVATE MODEL

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Methods for treating alzheimers disease and related dementias and aging using pegylated growth ho...
Invention Growth hormone receptor antagonists exhibiting increased receptor binding properties and increase...
2023 Invention Growth hormone antagonist and anti-cancer composition combination therapy. A composition for tre...
2022 P/S Development of new technology for others in the field of Biotechnology, namely, drug discovery se...
Invention Growth hormone antagonist and anti-cancer composition combination therapy. A composition for trea...
2021 Invention Apparatus and system for cooling. A cooling apparatus includes thermosyphon loops for cooling mu...
2020 Invention Therapeutic pegylated growth hormone antagonists. A growth hormone receptor antagonist, comprisin...
2019 Invention Pegylated growth hormone antagonists. A composition that is a human growth hormone receptor antag...